Fibrotic response to anti-CSF-1R therapy potentiates glioblastoma recurrence.

MLA

Watson, Spencer S., et al. “Fibrotic Response to Anti-CSF-1R Therapy Potentiates Glioblastoma Recurrence.” Cancer Cell, vol. 42, no. 9, Sept. 2024, p. 1507. EBSCOhost, https://doi.org/10.1016/j.ccell.2024.08.012.

APA

Watson, S. S., Zomer, A., Fournier, N., Lourenco, J., Quadroni, M., Chryplewicz, A., Nassiri, S., Aubel, P., Avanthay, S., Croci, D., Abels, E., Broekman, M. L. D., Hanahan, D., Huse, J. T., Daniel, R. T., Hegi, M. E., Homicsko, K., Cossu, G., Hottinger, A. F., & Joyce, J. A. (2024). Fibrotic response to anti-CSF-1R therapy potentiates glioblastoma recurrence. Cancer Cell, 42(9), 1507. https://doi.org/10.1016/j.ccell.2024.08.012

Chicago

Watson, Spencer S, Anoek Zomer, Nadine Fournier, Joao Lourenco, Manfredo Quadroni, Agnieszka Chryplewicz, Sina Nassiri, et al. 2024. “Fibrotic Response to Anti-CSF-1R Therapy Potentiates Glioblastoma Recurrence.” Cancer Cell 42 (9): 1507. doi:10.1016/j.ccell.2024.08.012.